By Professor Gordon Wishart, Chief Medical Officer at Check4Cancer & Visiting Professor of Cancer Surgery at Anglia Ruskin School of Medicine
Mon, 01/02/2021 - 12:00
Fri, 20/11/2020 - 12:18
Trevor Jones CBE, Director of Arix Bioscience plc and e-Therapeutics plc welcomed delegates, with opening remarks from Richard Torbett, Chief Executive Officer of ABPI.
Fri, 20/11/2020 - 12:16
The first fully virtual Bio Integrates got off to a flying start with interviews with Steve Bates, Chief Executive Officer, UK Bioindustry Association, and Sean Marett, Chief Business & Commercial Officer, BioNTech.
Thu, 29/10/2020 - 12:00
Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, delivers
Tue, 20/10/2020 - 10:06
The inaugural MedTech Integrates conference launched as a fully virtual event last Thursday, inspired by the ongoing success of the Pharma and Bio Integrates events.
Fri, 12/06/2020 - 15:45
As the Covid-19 pandemic continues to cause disruption across the country, it is likely that you will have seen delays and cancellations to your usual GP and outpatient appointments.
Tue, 28/04/2020 - 12:20
SynbiCITE’s London BioFoundry acts on the WHO recommendation of ‘Test, Test, Test’ to show how throughput can be significantly increased Re-thinking the approach to COVID-19 testing
Wed, 15/04/2020 - 14:32
A team of doctors have launched a website to support UK NHS healthcare workers (and hopefully beyond) in their practical training in the correct use of COVID-19 Pers
Fri, 10/04/2020 - 12:32
The world will never be the same again due to COVID-19, and the spread of the virus is showing little signs of slowing down.
Thu, 09/04/2020 - 11:24
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer (a leading early cancer detection and cancer prevention company) and Visiting Professor of Cancer Surgery at Angli